7.2 Anaemia, Coagulopathy, and Transfusion Medicine
Key Takeaways
Use MCV, the blood film and marrow response to organise the anaemia differential. Interpret ferritin with inflammation and investigate the cause of confirmed iron deficiency.
Suspected megaloblastic anaemia with neurological signs requires prompt B12 replacement. Folate alone can improve the blood count while neurological injury from B12 deficiency continues.
Schistocytic haemolysis with thrombocytopenia can be TTP even without the full pentad. Send ADAMTS13 samples if feasible and initiate urgent specialist-directed plasma exchange and corticosteroids when suspicion is high.
Haemophilia can cause deep bleeding and haemarthroses, while von Willebrand disease often causes mucosal bleeding. Confirm with appropriate factor or VWF tests.
Transfusion thresholds depend on the patient and indication. For suspected acute reactions, stop the component, assess the patient and alert the laboratory. Assess pulmonary oedema for evidence of overload and other causes.
Start with haemoglobin, cell size and marrow response
Use the laboratory reference range and clinical context. WHO 2024 defines anaemia at age 15–65 as haemoglobin below 130 g/L in men or below 120 g/L in non-pregnant women. In pregnancy, the WHO cutoffs are below 110 g/L in the first and third trimesters and below 105 g/L in the second. These are definitions, separate from thresholds for referral or transfusion.
Mean corpuscular volume (MCV) helps organise the differential: below 80 fL is usually microcytic, 80–100 fL normocytic and above 100 fL macrocytic in adults. Review the blood film, reticulocytes and other cell lines. A normal MCV can occur in mixed deficiency, early iron deficiency, recent bleeding or chronic disease.
Microcytosis and iron studies
| Pattern | Findings that help distinguish it |
|---|---|
| Iron deficiency | Low ferritin supports depleted stores. Transferrin or total iron-binding capacity often rises, transferrin saturation falls and the film may show hypochromia and pencil cells. |
| Thalassaemia trait | Marked microcytosis can coexist with mild or absent anaemia and a relatively high red cell count. Beta-thalassaemia trait often raises HbA₂. Adult alpha-thalassaemia trait can have an unremarkable haemoglobin analysis. |
| Inflammation | Hepcidin limits iron release by reducing ferroportin activity. Low serum iron and saturation can coexist with normal or high ferritin and low or normal transferrin. Iron deficiency may coexist. |
| Sideroblastic anaemia | Consider a clonal disorder, an inherited defect such as an ALAS2 variant, or an acquired cause such as alcohol, lead or isoniazid. Iron indices can be raised. Marrow iron staining can identify ring sideroblasts. |
Ferritin below 15 µg/L indicates absent stores in the BSG adult guidance, and below 30 µg/L generally indicates low stores. Inflammation can raise ferritin even when stores are depleted. Interpret with clinical context, inflammatory markers and transferrin saturation. Evaluate the cause of deficiency, including menstrual and other bleeding, malabsorption such as coeliac disease, and dietary insufficiency. In men and postmenopausal women with new unexplained iron deficiency anaemia, upper and lower GI assessment is generally indicated, with the local Irish referral pathway and patient fitness guiding investigation. The NCCP distinguishes gastroenterology, gynaecology or urology referral according to the likely source.
The Mentzer index divides MCV by the numerical red cell count in units of 10¹²/L. An MCV of 65 fL and count of 5.8 give about 11.2. A value below 13 is a clue to thalassaemia trait rather than a diagnosis. Check iron status and haemoglobin analysis. Interpret HbA₂ against the laboratory method and seek specialist or genetic assessment when appropriate. Iron deficiency and a trait can coexist.
WHO 2024 haemoglobin cutoffs · NCCP 2026 adult haematology referral manual · BSG adult iron deficiency guideline · EMQN haemoglobinopathy guidance · Mentzer report · RCPA sideroblastic anaemia
Macrocytosis and vitamin deficiency
Impaired DNA synthesis can produce macro-ovalocytes and hypersegmented neutrophils. Check vitamin B12 and folate as appropriate. B12 deficiency can follow autoimmune gastritis with loss of intrinsic factor, gastric or terminal ileal surgery, ileal disease or inadequate intake. Unfortified vegan diets can lack B12. Fortified foods and supplements can supply it. A positive intrinsic factor antibody supports autoimmune gastritis. A negative result leaves it possible. Folate deficiency can follow low intake, alcohol misuse, coeliac disease, increased requirements or antifolate medication.
B12 deficiency can cause neuropathy, loss of vibration or position sense, sensory ataxia and corticospinal signs. Neurological disease can occur with normal haemoglobin or MCV. Draw diagnostic blood samples before replacement when this can be done promptly. NICE advises treating suspected megaloblastic anaemia with neurological signs without waiting for results. Consider intramuscular replacement with significant neurological disease. If folate replacement is also needed, start B12 first or at the same time. Folate alone can improve blood counts while neurological injury from untreated B12 deficiency progresses.
NICE NG239 vitamin B12 deficiency · Irish folic acid product information
Interpret the blood film and reticulocyte response
Alcohol use, liver disease, hypothyroidism, some medicines, marrow disorders and reticulocytosis can cause macrocytosis without the typical nutritional film pattern. Review persistent macrocytosis with other cytopenias for marrow disease.
A high absolute reticulocyte count can suggest a marrow response to bleeding or haemolysis. In a markedly anaemic patient, an apparently high percentage can reflect a reduced denominator. The reticulocyte production index (RPI) corrects for both the degree of anaemia and early release of reticulocytes.
Using haematocrits of 0.24 and 0.45, a reticulocyte count of 6% and a maturation correction of 2 gives an index of about 1.6 on the conventional scale. This suggests a limited response despite the raw count. Interpret the index alongside timing, absolute reticulocytes, blood film, kidney function and possible marrow disease. A response to acute bleeding can take time.
Haemolysis and the direct antiglobulin test
Raised LDH and unconjugated bilirubin, low haptoglobin and reticulocytosis support haemolysis. The pattern can be incomplete. Free haemoglobin can cause dipstick positivity for blood with few or no red cells on microscopy. The direct antiglobulin test (DAT) helps identify immune haemolysis and must be interpreted with the clinical and laboratory findings.
- Warm autoimmune haemolytic anaemia is usually IgG-mediated, often with splenic clearance and spherocytes. Consider associated autoimmune disease or lymphoproliferative disease. Corticosteroids are usual first-line treatment and rituximab may be used in severe or refractory cases under haematology.
- Cold agglutinin disease typically involves clonal IgM with complement activation and a strongly C3d-positive DAT. Infections such as Mycoplasma or Epstein–Barr virus can cause secondary cold agglutinin syndromes. Keep the patient warm and involve haematology and transfusion services. Options for primary disease include selected rituximab-based regimens and sutimlimab, which is authorised in the EU for haemolytic anaemia in adults with cold agglutinin disease.
Reticulocyte calculation study · Adult autoimmune haemolytic anaemia consensus · EMA sutimlimab assessment
Microangiopathic haemolysis and thrombocytopenia
Schistocytes, haemolysis and thrombocytopenia warrant rapid evaluation for thrombotic microangiopathy and other causes, including DIC. Review the film and other tests with the patient's presentation.
| Pattern | Mechanism and clues | Immediate approach |
|---|---|---|
| Immune TTP | Autoantibodies produce severe ADAMTS13 activity deficiency, usually below 10%. Ultra-large VWF multimers promote platelet-rich microthrombi. Neurological signs can occur. PT and APTT are usually relatively normal. | Call haematology immediately. Draw ADAMTS13 activity and inhibitor samples before plasma therapy if possible. When suspicion is high, start therapeutic plasma exchange and corticosteroids without waiting. Specialists guide early caplacizumab and rituximab. |
| Shiga toxin-associated HUS | Anaemia from microangiopathic haemolysis, thrombocytopenia and kidney injury, often after bloody diarrhoea. | Seek urgent nephrology and supportive care, including dialysis when indicated. Test for STEC when appropriate. Avoid antimotility drugs in suspected STEC infection and seek advice before antibiotics because they can increase HUS risk. |
| Complement-mediated HUS | A distinct cause of thrombotic microangiopathy with prominent kidney injury. | Seek urgent specialist assessment for complement inhibition. Meningococcal risk and prevention need specific attention. |
| Disseminated intravascular coagulation | Systemic coagulation activation can accompany sepsis, trauma, malignancy or obstetric emergencies. Platelets and fibrinogen may fall and PT and fibrin-related markers can rise. Early tests can be less abnormal. | Treat the cause. Trend coagulation tests and use the applicable scoring framework. Give haemostatic components based on bleeding, procedures, laboratory trends and local protocols. |
TTP can present with microangiopathic haemolysis and thrombocytopenia before the classic pentad is present. Avoid routine prophylactic platelet transfusion. Serious bleeding or a high-risk invasive procedure may warrant specialist-directed use. A normal coagulation screen supports the differential but cannot by itself exclude early DIC.
ISTH 2025 TTP guideline and good-practice statements · ISTH 2025 DIC definition and scoring · BSH DIC management · CDC STEC clinical guidance · EMA ravulizumab information
Distinguish factor deficiencies, von Willebrand disease and immune thrombocytopenia
Haemophilia A and B. Factor VIII and IX deficiency, respectively, typically follow X-linked inheritance. Some females with an affected allele have low factor levels and clinically important bleeding. Deep muscle bleeding and recurrent painful haemarthroses are typical. PT is generally normal and APTT may be prolonged, but mild haemophilia can have a normal screening result. Confirm with factor activity assays. Correction of a prolonged APTT with a 1:1 mix suggests deficiency. An inhibitor can show incomplete correction or become apparent after incubation. Discuss significant bleeding urgently with the haemophilia centre. Factor replacement, desmopressin in selected responsive mild haemophilia A, and prophylaxis such as emicizumab for haemophilia A have different roles.
Von Willebrand disease. VWF mediates platelet adhesion and carries factor VIII. Mucosal bleeding, heavy menstrual bleeding, easy bruising and excessive bleeding after dental procedures are clues. Measure VWF antigen, platelet-dependent activity and factor VIII. The guideline prefers newer platelet-binding activity assays when available. VWF can rise during illness or stress, so baseline testing or repeat testing can matter. Treatment depends on subtype, bleeding and procedure. Options include tranexamic acid, VWF concentrate and desmopressin when appropriate and response is established or expected. Avoid desmopressin in type 2B and type 3.
Immune thrombocytopenia (ITP). Consider this with isolated thrombocytopenia and mucocutaneous bleeding after checking the film and excluding other causes. Significant splenomegaly or additional unexplained cytopenias call for a broader assessment. In adults with minor or no bleeding, observation can be appropriate. Use the platelet count, bleeding and individual risk to decide urgency. Corticosteroids and IV immunoglobulin have roles when treatment is indicated. The ASH 2026 adult update supports selected combination strategies with a thrombopoietic agent or rituximab and revises second-line choices. Critical bleeding requires emergency haematology and haemostatic treatment. Platelets can be indicated with IV immunoglobulin and high-dose corticosteroids and other appropriate adjuncts. Routine prophylactic transfusion for uncomplicated ITP is generally avoided.
WFH haemophilia guideline · VWD diagnosis guideline · VWD management guideline · ASH 2026 adult ITP guideline · 2026 critical bleeding in ITP guideline
Decide whether to transfuse and carry out bedside checks
Consider the clinical cause and symptoms, active bleeding, cardiovascular status and alternative treatments. A common restrictive threshold for haemodynamically stable hospitalised adults is 70 g/L. NICE NG24 suggests a post-transfusion target of 70–90 g/L for its general restrictive pathway and considers 80 g/L with a target of 80–100 g/L in ACS. The 2025 AABB guideline for acute myocardial infarction suggests a more liberal strategy below 100 g/L, conditionally with low-certainty evidence. Use the applicable local protocol and specialist input in myocardial ischaemia or major haemorrhage. In adults without active bleeding, consider one unit and reassess clinically and with haemoglobin before giving another.
Platelet thresholds are procedure- and diagnosis-specific. The 2025 AABB/ICTMG guideline gives examples below 10 × 10⁹/L in nonbleeding hypoproliferative thrombocytopenia during chemotherapy or allogeneic stem-cell transplantation, below 20 × 10⁹/L for lumbar puncture, and below 50 × 10⁹/L for major non-neuraxial surgery. Its threshold for a compressible-site adult central line is below 10 × 10⁹/L. These examples are not a universal procedure rule. Follow the local policy and consult for complex bleeding, critical-site surgery and neuraxial procedures.
Before administering a component, confirm the indication, consent or applicable emergency pathway, and special requirements. Positively identify the patient at the bedside with identifiers on the wristband and relevant records. Ask the patient to state their identifiers when possible. Check the prescription, compatibility label, donation number, component type, group compatibility, expiry and pack integrity under local policy. A discrepancy requires stopping the process and contacting the laboratory. Record baseline observations and monitor closely, especially during the first 15 minutes. Document administration, observations and component traceability.
NICE NG24 red cell recommendations · AABB 2023 red cell guideline · AABB 2025 acute myocardial infarction guideline · AABB/ICTMG 2025 platelet guideline · IBTS blood component administration guidance
Respond to a suspected acute transfusion reaction
Stop the transfusion, call for help and assess airway, breathing and circulation. Maintain IV access using new tubing or another line according to local policy. Recheck the patient and component identifiers, notify the transfusion laboratory promptly and retain the unit and giving set for investigation. Record symptoms and observations. Send requested samples and report through the local haemovigilance process.
| Suspected reaction | Clues and priorities |
|---|---|
| Acute haemolysis | Fever, rigors, back or flank pain, hypotension or haemoglobinuria can follow an incompatible component. Urgently investigate with the laboratory, including compatibility, DAT and haemolysis testing. Support perfusion and monitor renal function and coagulation. |
| Bacterial contamination | Fever, rigors and shock overlap with acute haemolysis. Obtain patient blood cultures and arrange culture of the implicated component through the laboratory. Start urgent IV antibiotics and sepsis care when suspected. |
| Febrile non-haemolytic reaction | Fever can be mild, but the diagnosis requires excluding more serious causes as appropriate. Obtain senior and transfusion advice before any decision to resume a stopped unit. |
| Anaphylaxis | Airway swelling, wheeze or shock can occur with or without skin findings. Give IM adrenaline promptly, with 500 micrograms of 1 mg/mL for an adult and a repeat after five minutes if needed. Support airway and circulation. The transfusion team advises on future components after investigation. |
| TRALI | New hypoxaemia and bilateral pulmonary oedema during or within six hours, with no substantial hydrostatic contribution explaining the deterioration. Give oxygen and ventilatory support as needed. Assess for other causes of acute lung injury and avoid routine diuresis unless there is an overload indication. |
| TACO | New respiratory compromise or pulmonary oedema during or up to 12 hours after transfusion, with evidence supporting hydrostatic overload. Clues include rising blood pressure, raised JVP, positive fluid balance and improvement with diuresis. Give oxygen as needed, position upright if tolerated and use diuresis when appropriate. |
Both pulmonary reactions can cause severe hypoxaemia and bilateral opacities. Use volume assessment, fluid balance, imaging and cardiac evaluation as appropriate. A single blood pressure or BNP value cannot reliably distinguish them. For future transfusions in patients at risk of TACO, reassess dose and rate and consider preventive measures individually.
IBTS National Haemovigilance handbook · EU haemovigilance definitions hosted by IBTS · BSH acute transfusion reactions guideline · TRALI consensus · Lifeblood reaction management
A 62-year-old male who has adhered to a strict vegan diet for 16 years presents to his general practitioner reporting six months of worsening fatigue, exertional breathlessness, symmetrical numbness and pins-and-needles in both feet, and unsteadiness when walking in the dark. Physical examination reveals conjunctival pallor, a smooth beefy-red tongue, impaired vibration sense to the costal margins, absent joint position sense in both feet, brisk knee reflexes with absent ankle jerks, and bilateral extensor plantar responses. Romberg test is positive. Laboratory investigations show haemoglobin 74 g/L, MCV 116 fL, white cell count 3.4 x 10^9/L, and platelets 112 x 10^9/L. The peripheral blood film reveals macro-ovalocytes and neutrophils with 5 to 7 nuclear lobes. Which of the following represents the most critical pharmacotherapeutic principle in managing this patient?
Administer high-dose oral folic acid 5 mg daily immediately while awaiting serum vitamin B12 levels to rapidly stimulate bone marrow erythropoiesis
Initiate immediate oral ferrous sulfate 200 mg three times daily to correct occult marrow iron stores and normalize red cell production
Transfuse two units of packed red blood cells immediately to rapidly elevate the haemoglobin concentration above 100 g/L
Take diagnostic samples promptly and start intramuscular vitamin B12 without waiting for results. If folate is also deficient, replace it after or alongside B12.
A 34-year-old previously healthy female presents to the emergency department with a 2-day history of fluctuating confusion, headache, petechial haemorrhages on both lower limbs, and dark urine. On examination, she is febrile at 38.3°C, blood pressure is 134/82 mmHg, heart rate is 96 bpm, and Glasgow Coma Scale score fluctuates between 12 and 14. Laboratory testing reveals haemoglobin 72 g/L, MCV 88 fL, platelets 16 x 10^9/L, serum creatinine 158 mcmol/L, total bilirubin 68 mcmol/L (predominantly unconjugated), serum LDH 1520 U/L (reference < 250), and serum haptoglobin < 0.05 g/L. The peripheral blood film demonstrates abundant schistocytes (helmet cells) and polychromasia. Coagulation screen shows PT/INR 1.0 (normal), APTT 28 seconds (normal), and fibrinogen 3.4 g/L (normal). The direct antiglobulin test (Coombs) is negative. Which initial emergency management is most appropriate?
Contact haematology urgently, send an ADAMTS13 sample before plasma therapy if possible, and start plasma exchange and corticosteroids. Avoid routine prophylactic platelets.
Give prophylactic platelets to raise the count above 50 × 10⁹/L and wait for ADAMTS13 results before consulting haematology
Start therapeutic unfractionated heparin as the primary treatment for microvascular thrombosis
Provide renal support alone and repeat the film and platelet count the next day
A 74-year-old female with a background history of ischemic heart disease and heart failure with preserved ejection fraction is admitted with an upper gastrointestinal bleed. Initial laboratory testing shows a haemoglobin of 62 g/L. Two hours into the transfusion of her second unit of packed red blood cells, she develops sudden severe dyspnoea, restlessness, and a dry cough. Her blood pressure rises from a baseline of 128/76 mmHg to 186/104 mmHg, heart rate is 114 bpm, respiratory rate is 32 breaths/min, and oxygen saturation drops to 84% on ambient air. Physical examination reveals an elevated jugular venous pressure of 6 cm above the sternal angle, an audible S3 gallop, and bilateral coarse crackles across the lower two-thirds of both lung fields. Chest radiography demonstrates cardiomegaly and bilateral perihilar alveolar bat-wing opacification. What is the most likely diagnosis, and what is the immediate management?
Transfusion-Related Acute Lung Injury (TRALI); manage with immediate high-dose intravenous hydrocortisone and vigorous volume resuscitation with 0.9% normal saline
Transfusion-associated circulatory overload. Stop the transfusion, assess airway and breathing, give oxygen, position upright if tolerated and treat overload with appropriate diuresis.
Acute Haemolytic Transfusion Reaction (AHTR); immediately administer intramuscular adrenaline and initiate vigorous crystalloid diuresis
Anaphylactic transfusion reaction; immediately intubate the patient, administer intravenous salbutamol, and continue the transfusion at a slower infusion rate
Sections you finish are checked off in the contents.